Correlation Between Arrowhead Pharmaceuticals and Moderna
Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arrowhead Pharmaceuticals and Moderna, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and Moderna.
Diversification Opportunities for Arrowhead Pharmaceuticals and Moderna
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Arrowhead and Moderna is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and Moderna go up and down completely randomly.
Pair Corralation between Arrowhead Pharmaceuticals and Moderna
Given the investment horizon of 90 days Arrowhead Pharmaceuticals is expected to generate 1.05 times more return on investment than Moderna. However, Arrowhead Pharmaceuticals is 1.05 times more volatile than Moderna. It trades about -0.03 of its potential returns per unit of risk. Moderna is currently generating about -0.06 per unit of risk. If you would invest 4,045 in Arrowhead Pharmaceuticals on August 29, 2024 and sell it today you would lose (1,940) from holding Arrowhead Pharmaceuticals or give up 47.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arrowhead Pharmaceuticals vs. Moderna
Performance |
| Timeline |
| Arrowhead Pharmaceuticals |
| Moderna |
Arrowhead Pharmaceuticals and Moderna Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arrowhead Pharmaceuticals and Moderna
The main advantage of trading using opposite Arrowhead Pharmaceuticals and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.The idea behind Arrowhead Pharmaceuticals and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Moderna vs. CureVac NV | Moderna vs. Novavax | Moderna vs. Ocean Biomedical | Moderna vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |